Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells 22,238 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 22,238 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $20.47, for a total transaction of $455,211.86. Following the completion of the sale, the insider owned 169,805 shares of the company’s stock, valued at $3,475,908.35. The trade was a 11.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Alignment Healthcare Price Performance

ALHC opened at $20.63 on Wednesday. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The stock has a market capitalization of $4.13 billion, a P/E ratio of -171.92, a price-to-earnings-growth ratio of 5.29 and a beta of 1.16. The company’s 50 day simple moving average is $20.85 and its 200-day simple moving average is $17.96. Alignment Healthcare, Inc. has a one year low of $11.63 and a one year high of $23.87.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. The Goldman Sachs Group restated a “buy” rating and set a $22.00 target price on shares of Alignment Healthcare in a research report on Monday, November 3rd. Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. JPMorgan Chase & Co. upped their target price on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, TD Cowen boosted their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a research note on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average target price of $23.32.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Larson Financial Group LLC acquired a new stake in Alignment Healthcare during the 3rd quarter worth approximately $33,000. First Horizon Corp bought a new stake in shares of Alignment Healthcare during the fourth quarter worth $39,000. SBI Securities Co. Ltd. raised its holdings in shares of Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after acquiring an additional 2,970 shares during the period. GAMMA Investing LLC raised its holdings in shares of Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after acquiring an additional 987 shares during the period. Finally, KBC Group NV bought a new stake in Alignment Healthcare in the 2nd quarter valued at $44,000. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.